Use of microphthalmia for diagnosis, prognosis and/or treatment of melanoma
US7338767B1 · kind B1 · utility
1Cited by
3References
5Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 13, 1999 |
| Grant date | Mar 4, 2008 |
| Priority date | — |
| Expiry date | Jan 13, 2019 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/4706
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Microphthalmia (Mi) while present in melanocytes, a cells and osteoclast, is not normally present in other cells. We have found that Mi is present in the nucleus of melanoma cells. Melanoma can be diagnosed by contacting a malignant cell with a probe for Mi. If the probe identifies Mi in the nucleus of the cell, the cell is a melanoma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.